Galenica AG
SIX:GALE

Watchlist Manager
Galenica AG Logo
Galenica AG
SIX:GALE
Watchlist
Price: 76 CHF -0.78% Market Closed
Market Cap: 3.8B CHF
Have any thoughts about
Galenica AG?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

GALE Price Targets Summary
Galenica AG

Wall Street analysts forecast GALE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GALE is 80.75 CHF with a low forecast of 73.73 CHF and a high forecast of 88.2 CHF.

GALE Lowest Forecast
Wall Street Target
73.73 CHF
3% Downside
GALE Average Forecast
Wall Street Target
80.75 CHF
6% Upside
GALE Highest Forecast
Wall Street Target
88.2 CHF
16% Upside
Lowest
Price Target
73.73 CHF
3% Downside
Average
Price Target
80.75 CHF
6% Upside
Highest
Price Target
88.2 CHF
16% Upside
Galenica AG Competitors:
Price Targets
000963
Huadong Medicine Co Ltd
16% Upside
FAGR
Fagron NV
21% Upside
Q
301015
Qingdao Baheal Medical Inc
80% Upside
7476
As One Corp
36% Upside
000963
Huadong Medicine Co Ltd
16% Upside
FAGR
Fagron NV
21% Upside
Q
301015
Qingdao Baheal Medical Inc
80% Upside
7476
As One Corp
36% Upside
SELEC.E
Selcuk Ecza Deposu Ticaret ve Sanayi AS
2% Upside
HLS
HLS Therapeutics Inc
71% Upside
AMP
Amplifon SpA
36% Upside
PGC
Paragon Care Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
Galenica AG

For the last 8 years the compound annual growth rate for Galenica AG's revenue is 3%. The projected CAGR for the next 3 years is 5%.

3%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Galenica AG

For the last 8 years the compound annual growth rate for Galenica AG's operating income is 7%. The projected CAGR for the next 3 years is 9%.

7%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Galenica AG

For the last 8 years the compound annual growth rate for Galenica AG's net income is 17%. The projected CAGR for the next 3 years is -11%.

17%
Past Growth
-11%
Estimated Growth
Estimates Accuracy
4%
Average Beat
What are analyst estimates?

See Also

Summary
GALE intrinsic value, competitors valuation, and company profile.
DCF Valuation
GALE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GALE stock valuation using valuation multiples.
Wall Street Estimates
GALE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GALE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GALE's stock price target?
Price Target
80.75 CHF

According to Wall Street analysts, the average 1-year price target for GALE is 80.75 CHF with a low forecast of 73.73 CHF and a high forecast of 88.2 CHF.

What is Galenica AG's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Galenica AG's revenue is 3%. The projected CAGR for the next 3 years is 5%.

What is Galenica AG's Operating Income forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Galenica AG's operating income is 7%. The projected CAGR for the next 3 years is 9%.

What is Galenica AG's Net Income forecast?
Projected CAGR
-11%

For the last 8 years the compound annual growth rate for Galenica AG's net income is 17%. The projected CAGR for the next 3 years is -11%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 204,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.